To achieve this, we produced Cyp17a1 KO rats and verified their obesity phenotype, assessing key components of metabolic syndrome including blood glucose levels, blood pressure, glucose tolerance, and insulin resistance. Here, CYP17A1 is linked to metabolic syndrome.